We’re excited to share our latest report on gene, cell, and rna therapies with The American Society of Gene and Cell Therapy (ASGCT). This Q3 2022 report calls out important updates and changes within the gene, cell, and rna therapy landscape.
Highlights of the report include:
Shardha Specialises in
We have received your request and we will get back to you soon.